Dear customers and partners,
at Molecular Health we share the global concern over the coronavirus pandemic. We want to assure you that we will maintain uninterrupted operation during these challenging times.
Strongly mutated tumors are more likely to generate neoantigens that are recognized as foreign by immune cells. Tumors with a high TMB can therefore have a high immunogenicity.
Molecular Health is featured in a case study of DrugBank, the world’s largest online database of drug and drug target information.
Klicken Sie auf den unteren Button, um den Inhalt von www.linkedin.com zu laden.
Dataome has become one of the largest globally available resources of clinico-molecular data and knowledge. From millions of patient lives to hundreds of billions of molecular data points, it provides a single point of access to the world’s biomedical knowledge through our decision support applications.
Molecular Health Predict (MH Predict) is an application to predict clinical trials probabilities of success. It enables the improvement of clinical trial success and reduces clinical trial failure while optimizing resource allocation for the biopharma industry and investors and enhancing the overall efficiency of drug development.
Molecular Health Guide Mendel (MH Mendel) supports human geneticists in diagnosing hereditary diseases and creating diagnostic reports for individuals. The germline data analysis follows official genetic guidelines and uses the latest, world known ACMG variant classification criteria.
Molecular Health Guide (MH Guide) identifies safe and effective medication for cancer patients by analyzing the cancer’s molecular profile. It matches detected tumor mutations to the world’s knowledge in the field of oncology and helps medical experts to create a patient-specific clinical report with treatment recommendations.
Molecular Health Guide BRCA (MH BRCA) supports medical professionals in identifying and reporting clinically significant germline variants for hereditary breast and ovarian cancer. It creates individual patient reports based on NGS data from BRCA1/BRCA2 and other associated genes following official genetic guidelines.
Molecular Health’s growing number of customers and partnerships include some of the best hospitals, laboratories, universities, and genetic facilities in the world.
To find out more, you can call our customer service or send us an e-mail. We would be delighted to provide you with more information or answer your questions.
Phone: +1 978-491-8393
Fax: +1-978-456-3080
E-mail: CustomerCareUS@molecularhealth.com
